SG11202007136VA - Triazine derivatives for treating diseases relating to neurotrophins - Google Patents
Triazine derivatives for treating diseases relating to neurotrophinsInfo
- Publication number
- SG11202007136VA SG11202007136VA SG11202007136VA SG11202007136VA SG11202007136VA SG 11202007136V A SG11202007136V A SG 11202007136VA SG 11202007136V A SG11202007136V A SG 11202007136VA SG 11202007136V A SG11202007136V A SG 11202007136VA SG 11202007136V A SG11202007136V A SG 11202007136VA
- Authority
- SG
- Singapore
- Prior art keywords
- neurotrophins
- treating diseases
- triazine derivatives
- diseases relating
- relating
- Prior art date
Links
- 108010025020 Nerve Growth Factor Proteins 0.000 title 1
- 102000007072 Nerve Growth Factors Human genes 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 150000003918 triazines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/30—Only oxygen atoms
- C07D251/34—Cyanuric or isocyanuric esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/30—Only oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1850217 | 2018-02-26 | ||
GBGB1810667.4A GB201810667D0 (en) | 2018-06-28 | 2018-06-28 | New compounds and uses |
PCT/GB2019/050523 WO2019162702A1 (en) | 2018-02-26 | 2019-02-26 | Triazine derivatives for treating diseases relating to neurotrophins |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202007136VA true SG11202007136VA (en) | 2020-08-28 |
Family
ID=65729389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202007136VA SG11202007136VA (en) | 2018-02-26 | 2019-02-26 | Triazine derivatives for treating diseases relating to neurotrophins |
Country Status (24)
Country | Link |
---|---|
US (2) | US11352332B2 (en) |
EP (1) | EP3759088B8 (en) |
JP (1) | JP7350759B2 (en) |
KR (1) | KR20200126988A (en) |
CN (1) | CN111819172B (en) |
AU (1) | AU2019223333B2 (en) |
BR (1) | BR112020017341A2 (en) |
CA (1) | CA3090864A1 (en) |
CL (1) | CL2020002157A1 (en) |
DK (1) | DK3759088T3 (en) |
ES (1) | ES2941529T3 (en) |
FI (1) | FI3759088T3 (en) |
HR (1) | HRP20230290T1 (en) |
HU (1) | HUE061751T2 (en) |
IL (1) | IL276624B2 (en) |
LT (1) | LT3759088T (en) |
MA (1) | MA52415A (en) |
MX (1) | MX2020008816A (en) |
PL (1) | PL3759088T3 (en) |
PT (1) | PT3759088T (en) |
SG (1) | SG11202007136VA (en) |
SI (1) | SI3759088T1 (en) |
WO (1) | WO2019162702A1 (en) |
ZA (1) | ZA202004220B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201810668D0 (en) | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
GB201912404D0 (en) * | 2019-08-29 | 2019-10-16 | AlzeCure Pharma AB | New compounds |
CN113831298B (en) * | 2020-06-23 | 2023-12-01 | 沈阳中化农药化工研发有限公司 | Photoactive carboxylic acid ester compound and application thereof |
AU2021297861B2 (en) * | 2020-06-23 | 2024-03-07 | Jiangsu Yangnong Chemical Co., Ltd. | Triazine benzoate compound and application thereof |
CN113831299B (en) * | 2020-06-23 | 2023-12-01 | 沈阳中化农药化工研发有限公司 | Benzoate compound and application thereof |
CN118216517A (en) * | 2022-12-21 | 2024-06-21 | 沈阳中化农药化工研发有限公司 | Weeding composition and application thereof |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2246109A1 (en) * | 1972-09-20 | 1974-03-28 | Bayer Ag | 1- (4-PHENOXY-PHENYL) -1,3,5-TRIAZINE DERIVATIVES, A METHOD FOR THEIR MANUFACTURE AND THEIR USE AS A MEDICINAL PRODUCT |
DE2313721A1 (en) * | 1973-03-20 | 1974-10-03 | Bayer Ag | NEW 1-PHENYL-SUBSTITUTED 1,3,5TRIAZINE, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT |
DE2413722C3 (en) * | 1974-03-21 | 1982-04-08 | Bayer Ag, 5090 Leverkusen | New 1- (4-phenoxyphenyl) -1,3,5-triazine derivatives, a process for their preparation and their use as pharmaceuticals |
DE2718799A1 (en) | 1977-04-27 | 1978-11-09 | Bayer Ag | 1- (4-PHENOXY-PHENYL) -1,3,5-TRIAZINE DERIVATIVES, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT AND GROWTH PROMOTER |
CA1185974A (en) | 1981-12-03 | 1985-04-23 | Adolf Parg | 1,3,5-triazinones and their use for controlling undesirable plant growth |
DE3314739A1 (en) | 1983-04-23 | 1984-10-25 | Bayer Ag, 5090 Leverkusen | 1- (4- (4- (FLUORALKYLMETHYLTHIO- OR -SULFINYL- OR -SULFONYL-) PHENOXY) PHENYL) -1,3,5-TRIAZINE-2,4,6 (1H, 3H, 5H) -TRIONE, PROCEDURE TO THEIR PRODUCTION AND USE AS COCCIDIOS |
DE3408768A1 (en) * | 1984-03-09 | 1985-09-12 | Bayer Ag, 5090 Leverkusen | IMMUNTIMULATING AGENTS |
DE3516632A1 (en) | 1985-05-09 | 1986-11-13 | Bayer Ag, 5090 Leverkusen | METHOD FOR PRODUCING 1,3,5-TRIAZINTRIONS |
DE3516631A1 (en) | 1985-05-09 | 1986-11-13 | Bayer Ag, 5090 Leverkusen | Process for the preparation of 3-methyl-1,3,5-triazinetriones |
DE3703105A1 (en) | 1987-02-03 | 1988-08-11 | Bayer Ag | MEDICINE AGAINST PROTOCOES IN INSECTS |
DE3810080A1 (en) | 1988-03-25 | 1989-10-05 | Bayer Ag | TRISUBSTITUTED 1,3,5-TRIAZINE-2,4,6-TRIONE |
DE3814323A1 (en) | 1988-04-28 | 1989-11-09 | Hoechst Ag | WATER-SOLUBLE PREPARATIONS BY COCCIDIOSTATICA |
US4933341A (en) | 1988-10-08 | 1990-06-12 | Bayer Aktiengesellschaft | Substituted 1,3,5-triazinetriones, for use against parasitic protozoa |
DE4000624A1 (en) | 1990-01-11 | 1991-07-18 | Bayer Ag | New tri:substd.-1,3,5-triazine-2,4,6-tri:one derivs. - for use as fungicides in plant protection |
DE4329096A1 (en) | 1993-08-30 | 1995-03-02 | Bayer Ag | Heterocyclylbenzoheterocycles |
US5604180A (en) | 1995-06-02 | 1997-02-18 | Crews, Jr.; Alvin D. | 3-(3-aryloxyphenyl)-1 (substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents |
US5726126A (en) | 1995-06-02 | 1998-03-10 | American Cyanamid Company | 1-(3-heterocyclyphenyl)-S-triazine-2,6,6-oxo or thiotrione herbicidal agents |
US5519133A (en) | 1995-06-02 | 1996-05-21 | American Cyanamid Co. | 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents |
CZ146296A3 (en) | 1995-06-02 | 1997-04-16 | American Cyanamid Co | 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotriones, process of their preparation and herbicidal agents |
US5679791A (en) | 1996-07-25 | 1997-10-21 | American Cyanamid Company | 1-(3-heterocyclylphenyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents |
CN1189175C (en) | 1998-10-08 | 2005-02-16 | 高新研究公司 | Novel compsns. and methods for prevention and treatment of protozoal disease |
AU2198100A (en) | 1998-12-22 | 2000-07-12 | Bayer Corporation | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
DE19937500A1 (en) | 1999-08-09 | 2001-02-15 | Bayer Ag | Substituted heterocyclylbenzofurans |
DE19958388A1 (en) | 1999-12-03 | 2001-06-07 | Bayer Ag | Triazinone compounds for the treatment of infestations with parasitic protozoa-related diseases |
US6444615B1 (en) | 2000-04-18 | 2002-09-03 | Dow Agrosciences Llc | Herbicidal imidazolidinetrione and thioxo-imidazolidinediones |
DE10034800A1 (en) | 2000-07-18 | 2002-01-31 | Bayer Ag | Substituted benzo nitrogen heterocycles |
DE10040174A1 (en) | 2000-08-17 | 2002-02-28 | Bayer Ag | Treatment of coccidiosis comprises administration of haloalkylsulfonyl substituted phenoxyphenyl-triazinetrione derivatives |
DE10040110A1 (en) | 2000-08-17 | 2002-02-28 | Bayer Ag | Use of triazinetrione sulfoxides to combat coccidioses |
AU2002324586B2 (en) | 2001-08-02 | 2008-04-24 | Neurocrine Biosciences, Inc. | 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
US20040259912A1 (en) | 2001-09-28 | 2004-12-23 | Takahiro Matsumoto | Benzine derivatives, process for preparing the same and use thereof |
US6861523B2 (en) | 2002-02-08 | 2005-03-01 | Torrey Pines Institute For Molecular Studies | 1,3,5- trisubstituted-1,3,5-triazine-2,4,6-trione compounds and libraries |
ES2282673T3 (en) | 2002-07-15 | 2007-10-16 | Janssen Pharmaceutica N.V. | TOXOFLAVIN 3-FURANILO ANALOGS AS KINASE INHIBITORS. |
DE102006038292A1 (en) | 2006-08-16 | 2008-02-21 | Bayer Healthcare Ag | Transdermal use of triazines to combat coccidial infections |
WO2008148008A1 (en) | 2007-05-23 | 2008-12-04 | Emory University | High throughput bioassay for identifying selective trka receptor agonists, and gambogic amide, a selective trka agonist with neuroprotective activity |
RU2016131875A (en) | 2014-01-20 | 2018-02-26 | Ф. Хоффманн-Ля Рош Аг | N-Phenyllactam derivatives capable of stimulating neurogenesis and their use in the treatment of diseases of the nerve system |
CN106998771B (en) | 2014-12-10 | 2021-06-22 | 马斯公司 | Flavour composition and pet food comprising same |
WO2018115891A1 (en) * | 2016-12-21 | 2018-06-28 | Stiftelsen Alzecure | Triazinetrione derivatives and their use as modulators of neurotrophin receptor and receptor tyrosine kinases |
GB201810669D0 (en) | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
GB201810668D0 (en) | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
-
2019
- 2019-02-26 MX MX2020008816A patent/MX2020008816A/en unknown
- 2019-02-26 HU HUE19710473A patent/HUE061751T2/en unknown
- 2019-02-26 EP EP19710473.0A patent/EP3759088B8/en active Active
- 2019-02-26 AU AU2019223333A patent/AU2019223333B2/en active Active
- 2019-02-26 JP JP2020544648A patent/JP7350759B2/en active Active
- 2019-02-26 WO PCT/GB2019/050523 patent/WO2019162702A1/en active Application Filing
- 2019-02-26 FI FIEP19710473.0T patent/FI3759088T3/en active
- 2019-02-26 IL IL276624A patent/IL276624B2/en unknown
- 2019-02-26 PT PT197104730T patent/PT3759088T/en unknown
- 2019-02-26 SI SI201930505T patent/SI3759088T1/en unknown
- 2019-02-26 PL PL19710473.0T patent/PL3759088T3/en unknown
- 2019-02-26 DK DK19710473.0T patent/DK3759088T3/en active
- 2019-02-26 CA CA3090864A patent/CA3090864A1/en active Pending
- 2019-02-26 US US16/975,437 patent/US11352332B2/en active Active
- 2019-02-26 BR BR112020017341-0A patent/BR112020017341A2/en unknown
- 2019-02-26 MA MA052415A patent/MA52415A/en unknown
- 2019-02-26 ES ES19710473T patent/ES2941529T3/en active Active
- 2019-02-26 HR HRP20230290TT patent/HRP20230290T1/en unknown
- 2019-02-26 CN CN201980014798.6A patent/CN111819172B/en active Active
- 2019-02-26 LT LTEPPCT/GB2019/050523T patent/LT3759088T/en unknown
- 2019-02-26 SG SG11202007136VA patent/SG11202007136VA/en unknown
- 2019-02-26 KR KR1020207025764A patent/KR20200126988A/en not_active Application Discontinuation
-
2020
- 2020-07-09 ZA ZA2020/04220A patent/ZA202004220B/en unknown
- 2020-08-21 CL CL2020002157A patent/CL2020002157A1/en unknown
-
2022
- 2022-06-02 US US17/830,724 patent/US20220306589A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
LT3759088T (en) | 2023-05-10 |
WO2019162702A1 (en) | 2019-08-29 |
MX2020008816A (en) | 2020-09-28 |
CL2020002157A1 (en) | 2020-12-18 |
CA3090864A1 (en) | 2019-08-29 |
KR20200126988A (en) | 2020-11-09 |
PT3759088T (en) | 2023-04-10 |
US20220306589A1 (en) | 2022-09-29 |
AU2019223333A1 (en) | 2020-08-27 |
EP3759088B8 (en) | 2023-03-08 |
ES2941529T3 (en) | 2023-05-23 |
MA52415A (en) | 2021-01-06 |
IL276624B2 (en) | 2023-10-01 |
IL276624A (en) | 2020-09-30 |
SI3759088T1 (en) | 2023-07-31 |
HRP20230290T1 (en) | 2023-05-26 |
EP3759088A1 (en) | 2021-01-06 |
RU2020126542A (en) | 2022-03-29 |
ZA202004220B (en) | 2023-12-20 |
HUE061751T2 (en) | 2023-08-28 |
JP7350759B2 (en) | 2023-09-26 |
BR112020017341A2 (en) | 2020-12-15 |
AU2019223333B2 (en) | 2024-06-20 |
JP2021514963A (en) | 2021-06-17 |
US20200399230A1 (en) | 2020-12-24 |
IL276624B1 (en) | 2023-06-01 |
EP3759088B1 (en) | 2023-01-25 |
US11352332B2 (en) | 2022-06-07 |
CN111819172A (en) | 2020-10-23 |
PL3759088T3 (en) | 2023-07-03 |
DK3759088T3 (en) | 2023-03-27 |
CN111819172B (en) | 2024-02-06 |
FI3759088T3 (en) | 2023-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3759088T3 (en) | Triazine derivatives for treating diseases relating to neurotrophins | |
HK1258588A1 (en) | Compounds and formulations for treating ophthalmic diseases | |
IL277190A (en) | Methods for treating hpv-associated diseases | |
PT3600309T (en) | Therapeutic combinations for treating liver diseases | |
SG11201705093UA (en) | Composition for treating il-6-related diseases | |
PL3728271T3 (en) | Macrocyclic compounds for treating diseases | |
IL277333A (en) | Methods for treating ocular diseases | |
HK1256795A1 (en) | Bipyrazolyl derivatives useful for the treatment of autoimmune diseases | |
DK3953357T3 (en) | Pyrrolotriazine derivatives for treating KIT- and PDGFRA-mediated diseases | |
IL292429B2 (en) | Improved process for preparing aminopyrimidine derivatives | |
EP3411399A4 (en) | Antibody-drug synergism technology for treating diseases | |
IL259297A (en) | Heterocyclic compounds for the treatment of disease | |
SG11202108636SA (en) | Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer |